Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging
SKT Que, FO Zwald, CD Schmults - Journal of the American Academy of …, 2018 - Elsevier
Cutaneous squamous cell carcinoma (cSCC), a malignant proliferation of cutaneous
epithelium, represents 20% to 50% of skin cancers. Although the majority of cSCCs are …
epithelium, represents 20% to 50% of skin cancers. Although the majority of cSCCs are …
Cutaneous squamous cell carcinoma
A Waldman, C Schmults - Hematology/Oncology Clinics, 2019 - hemonc.theclinics.com
Cutaneous squamous cell carcinoma (cSCC) is the second most common nonmelanoma
skin cancer. It accounts for 20% of skin cancer and results in 1 million cases in the United …
skin cancer. It accounts for 20% of skin cancer and results in 1 million cases in the United …
Guidelines of care for the management of cutaneous squamous cell carcinoma
M Alam, A Armstrong, C Baum, JS Bordeaux… - Journal of the American …, 2018 - Elsevier
Cutaneous squamous cell carcinoma (cSCC) is the second most common form of human
cancer and has an increasing annual incidence. Although most cSCC is cured with office …
cancer and has an increasing annual incidence. Although most cSCC is cured with office …
[HTML][HTML] European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention
AJ Stratigos, C Garbe, C Dessinioti, C Lebbe… - European journal of …, 2020 - Elsevier
Invasive cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers in
the white populations, accounting for 20% of all cutaneous malignancies. Factors implicated …
the white populations, accounting for 20% of all cutaneous malignancies. Factors implicated …
Update on keratinocyte carcinomas
KS Nehal, CK Bichakjian - New England Journal of Medicine, 2018 - Mass Medical Soc
Update on Keratinocyte Carcinomas | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis
AK Thompson, BF Kelley, LJ Prokop… - JAMA …, 2016 - jamanetwork.com
Importance To date, the magnitude of association and the quality of evidence for cutaneous
squamous cell carcinoma (cSCC) and risk factors for outcomes have not been reviewed and …
squamous cell carcinoma (cSCC) and risk factors for outcomes have not been reviewed and …
Cutaneous squamous cell carcinoma: a review of high-risk and metastatic disease
KA Burton, KA Ashack, A Khachemoune - American journal of clinical …, 2016 - Springer
Non-melanoma skin cancer represents one-third of all malignancies and its incidence is
expected to rise until the year 2040. Cutaneous squamous cell carcinoma (cSCC) …
expected to rise until the year 2040. Cutaneous squamous cell carcinoma (cSCC) …
[HTML][HTML] Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight …
D Rischin, MR Migden, AM Lim… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Original research: Phase 2 study of cemiplimab in patients with metastatic cutaneous
squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based …
squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based …
Performance of the American Joint Committee on Cancer Staging Manual, vs the Brigham and Women's Hospital tumor classification system for cutaneous squamous …
Importance Brigham and Women's tumor classification (BWH) better predicts poor outcomes
than American Joint Committee on Cancer (AJCC) 7th edition (AJCC 7). AJCC 8th edition …
than American Joint Committee on Cancer (AJCC) 7th edition (AJCC 7). AJCC 8th edition …
[HTML][HTML] Skin cancers in organ transplant recipients
A Mittal, OR Colegio - American Journal of Transplantation, 2017 - Elsevier
Long-term utilization of immunosuppression in organ transplant recipients (OTRs) leads to
decreased immune-mediated tumor surveillance and development of malignant tumors. A …
decreased immune-mediated tumor surveillance and development of malignant tumors. A …